Tibet Cheezheng Tibetan Medicine Co Ltd Market Cap ($1.62 Billion)
Market Cap & Net Worth: Tibet Cheezheng Tibetan Medicine Co Ltd (002287)
Tibet Cheezheng Tibetan Medicine Co Ltd market cap. Tibet Cheezheng Tibetan Medicine Co Ltd (SHE:002287) has a market capitalization of $1.62 Billion (CN¥11.09 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #6663 globally and #1293 in its home market, demonstrating a 0.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tibet Cheezheng Tibetan Medicine Co Ltd's stock price CN¥19.38 by its total outstanding shares 572118203 (572.12 Million). Also see 002287 cash flow metrics for how efficiently the company converts equity into cash flow.
Tibet Cheezheng Tibetan Medicine Co Ltd Market Cap History (2015–2026)
Tibet Cheezheng Tibetan Medicine Co Ltd market cap history from 2015 to 2026. Data shows growth from $2.32 Billion to $1.62 Billion (0.01% CAGR). Check latest Tibet Cheezheng Tibetan Medicine Co Ltd stock price today for real-time trading data and today's change.
Tibet Cheezheng Tibetan Medicine Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tibet Cheezheng Tibetan Medicine Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset momentum of Tibet Cheezheng Tibetan Medicine Co Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.82x
Tibet Cheezheng Tibetan Medicine Co Ltd's market cap is 0.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.07x
Tibet Cheezheng Tibetan Medicine Co Ltd's market cap is 3.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.50 Billion | $968.35 Million | $289.86 Million | 2.58x | 8.63x |
| 2017 | $1.93 Billion | $1.05 Billion | $300.84 Million | 1.83x | 6.42x |
| 2018 | $1.45 Billion | $1.21 Billion | $318.77 Million | 1.19x | 4.54x |
| 2019 | $1.66 Billion | $1.40 Billion | $364.25 Million | 1.18x | 4.55x |
| 2020 | $2.01 Billion | $1.49 Billion | $403.96 Million | 1.35x | 4.97x |
| 2021 | $2.40 Billion | $1.77 Billion | $715.88 Million | 1.35x | 3.35x |
| 2022 | $1.84 Billion | $2.04 Billion | $472.54 Million | 0.90x | 3.88x |
| 2023 | $1.84 Billion | $2.05 Billion | $581.20 Million | 0.90x | 3.16x |
| 2024 | $1.79 Billion | $2.34 Billion | $582.28 Million | 0.77x | 3.08x |
| 2025 | $1.98 Billion | $2.42 Billion | $646.23 Million | 0.82x | 3.07x |
Competitor Companies of 002287 by Market Capitalization
Companies near Tibet Cheezheng Tibetan Medicine Co Ltd in the global market cap rankings as of November 4, 2026. Also see 002287 total assets for a full breakdown of the balance sheet.
Key companies related to Tibet Cheezheng Tibetan Medicine Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Tibet Cheezheng Tibetan Medicine Co Ltd (2015–2026)
Market capitalization of Tibet Cheezheng Tibetan Medicine Co Ltd from 2015 to today. Between 2015 and today, Tibet Cheezheng Tibetan Medicine Co Ltd's market cap moved from $2.32 Billion to $ 1.62 Billion, with a yearly change of 0.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.62 Billion | -18.09% |
| 2025 | CN¥1.98 Billion | +10.56% |
| 2024 | CN¥1.79 Billion | -2.46% |
| 2023 | CN¥1.84 Billion | +0.09% |
| 2022 | CN¥1.84 Billion | -23.39% |
| 2021 | CN¥2.40 Billion | +19.35% |
| 2020 | CN¥2.01 Billion | +21.09% |
| 2019 | CN¥1.66 Billion | +14.59% |
| 2018 | CN¥1.45 Billion | -25.11% |
| 2017 | CN¥1.93 Billion | -22.81% |
| 2016 | CN¥2.50 Billion | +7.64% |
| 2015 | CN¥2.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Tibet Cheezheng Tibetan Medicine Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.62 Billion USD |
| MoneyControl | $1.62 Billion USD |
| MarketWatch | $1.62 Billion USD |
| marketcap.company | $1.62 Billion USD |
| Reuters | $1.62 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tibet Cheezheng Tibetan Medicine Co Ltd
Tibet Cheezheng Tibetan Medicine Co., Ltd. engages in the research, development, production, and sale of Tibetan medicines in China and internationally. The company also provides plasters, topical and oral tibetan medicines, and ointments. Its products are used in areas of orthopedics, neurology, dermatology, granules, gynecology, pediatrics, respiratory, gastroenterology, cardiovascular, musculo… Read more